Stock ASPN ASPEN AEROGELS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Aspen Aerogels, Inc.

Equities

ASPN

US04523Y1055

Market Closed - Nyse
Other stock markets
 16:00:02 2024-05-03 EDT 		5-day change 1st Jan Change
25.11 USD +5.28% Intraday chart for Aspen Aerogels, Inc. +55.96% +59.13%
05-03 B. Riley Adjusts Aspen Aerogels Price Target to $30 From $24, Maintains Buy Rating MT
05-02 Materials Slip Amid Mixed Earnings -- Materials Roundup DJ

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • Analysts covering this company mostly recommend stock overweighting or purchase.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 379.02 times its estimated earnings per share for the ongoing year.
  • The company's enterprise value to sales, at 4.97 times its current sales, is high.
  • The company appears highly valued given the size of its balance sheet.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
ASPEN AEROGELS, INC. Stock Aspen Aerogels, Inc.
+59.13% 1.91B
C
ECOLAB INC. Stock Ecolab Inc.
+14.70% 65.04B
A-
SIKA AG Stock Sika AG
-1.61% 47.76B
A-
GIVAUDAN SA Stock Givaudan SA
+14.58% 40.72B
B+
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+20.84% 26.88B
A-
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+9.54% 19.29B
C+
CELANESE CORPORATION Stock Celanese Corporation
+1.16% 17.53B
B+
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.87% 16.03B
A-
SYMRISE AG Stock Symrise AG
+1.11% 15.17B
B+
ALBEMARLE CORPORATION Stock Albemarle Corporation
-11.34% 15.06B
C+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ASPN Stock
  4. Ratings Aspen Aerogels, Inc.